Association between serum omega-3 to omega-6 polyunsaturated fatty acid ratio and cardiovascular events in a general Japanese population

Atherosclerosis

Volumn 231, Issue 2, 2013, Pages 281-282

  Momiyama, Yukihiko ^a  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Arachidonic acid (AA); C reactive protein; Cardiovascular disease; Coronary heart disease; Eicosapentaenoic acid (EPA); Stroke

Indexed keywords

C REACTIVE PROTEIN; COLLAGEN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CORRELATION ANALYSIS; DIETARY INTAKE; DISEASE ASSOCIATION; FATTY ACID BLOOD LEVEL; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; INFLAMMATORY CELL; ISCHEMIC HEART DISEASE; JAPANESE; LACUNAR STROKE; MACROPHAGE; MORTALITY; NONHUMAN; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; STABLE ANGINA PECTORIS; THROMBOCYTE AGGREGATION; TRIACYLGLYCEROL BLOOD LEVEL;

ARACHIDONIC ACID (AA); C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASE; CORONARY HEART DISEASE; EICOSAPENTAENOIC ACID (EPA); STROKE;

ARACHIDONIC ACID; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CORONARY DISEASE; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; MALE;

EID: 84888101001     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.09.032     Document Type: Note

References (19)

1. Calder P.C. The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res 2012, 56:1073-1080.
2. James M.J., Gibson R.A., Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000, 71:343S-348S.
3. Nakakuki M., Kawano H., Notsu T., et al. Eicosapentaenoic acid suppresses palmitate-induced cytokine production by modulating long-chain acyl-CoA synthetase 1 expression in human THP-1 macrophages. Atherosclerosis 2013, 227:289-296.
4. Iso H., Rexrode K.M., Stampfer M.J., et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAm Med Assoc 2001, 285:304-312.
5. Hu F.B., Bronner L., Willett W.C., et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAm Med Assoc 2002, 287:1815-1821.
6. Iso H., Kobayashi M., Ishihara J., et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort 1. Circulation 2006, 113:195-202.
7. Wang C., Harris W.S., Chung M., et al. n-3 fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006, 84:5-17.
8. Iso H., Sato S., Folsom A.R., et al. Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men. Int J Epidemiol 1989, 18:374-381.
9. Lemaitre R.N., King I.B., Mozaffarian D., et al. n-3 polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr 2003, 77:319-325.
10. Domei T., Yokoi H., Kuramitsu S., et al. Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention. Circ J 2012, 76:423-429.
11. Hagi A., Nakayama M., Shinzaki W., et al. Effects of the omega-6:omega-3 fatty acid ratio of fat emulsions on the fatty acid composition in cell membranes and the anti-inflammatory action. JParenter Enteral Nutr 2010, 34:263-270.
12. Hayakawa S., Yoshikawa D., Ishii H., et al. Association of plasma omega-3 to omega-6 polyunsaturated fatty acid ratio with complexity of coronary artery lesion. Intern Med 2012, 51:1009-1014.
13. Ninomiya T., Nagata M., Hata J., et al. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study. Atherosclerosis 2013, 231:261-267.
14. Harris W.S., Miller M., Tighe A.P., et al. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008, 197:12-24.
15. Matsumoto M., Sata M., Fukuda D., et al. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. Atherosclerosis 2008, 197:524-533.
16. Cawood A.L., Ding R., Napper F.L., et al. Eicosapentaenoic acid from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis 2010, 212:252-259.
17. Lee S.H., Shin M.J., Kim J.S., et al. Blood eicosapentaenoic acid and docosahexaenoic acid as predictors of all-cause mortality in patients with acute myocardial infarction: data from Infarction Prognosis Study (IPS) Registry. Circ J 2009, 73:2250-2257.
18. Sun Q., Ma J., Campos H., et al. Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. Am J Clin Nutr 2008, 88:216-223.
19. Zampolli A., Bysted A., Leth T., et al. Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. Atherosclerosis 2006, 184:78-85.